Several treatment methods have been determined exclusively for women with<unk> . A great majority of these therapies include progestogens (naturally occurring) or progestins (synthetic progestogen). Drug interactions are an important factor when using progesterone therapy, as many antiseizure medications augment hepatic metabolism of gonadal steroids, and increase serum protein binding to hormones. There are many unfortunate side effects frequently seen in progesterone therapy usage, including vaginal dryness, dyspareunia, osteoporosis, and cardiovascular disease. * Cyclic progesterone therapy supplements the patient with natural progesterone during the luteal phase when progesterone is normally low, and gradually reduces the supplementation premenstrually. * Suppressive progestin therapy intends to suppress the menstrual cycle entirely by using injectable progestins or gonadotropin-releasing hormones (GnRH). GnRH basically mimics an ovary-free environment in the female, which is characteristic of the lack of menstrual cycle during menopause. A 2019 Cochrane review found low certainty evidence of no treatment difference between norethisterone and placebo and moderate to low certainty of the no difference with progesterone versus placebo. The review did note however that important clinical effects could not be ruled out due to the small and under powered nature of the studies reviewed.
Catamenial epilepsy
Rolandic epilepsy
Musicogenic epilepsy
Frontal lobe epilepsy
Childhood absence epilepsy
Northern epilepsy syndrome
Temporal lobe epilepsy
Progressive myoclonus epilepsy